department of chemical engineering
  news and events
Chemical Engineering and the Department News, events and seminars Faculty, staff, students, post-docs, visitors Undergraduate program in ChE Graduate program in ChE Topics and people Careers and recruiting Resources for ChE faculty, staff and students
news, events and seminars
seminar schedule
frontiers in biotech
hottel lecture
lewis lecture
michaels lecture
back to
welcome alumni
positions open
visting the dept.
whom to contact
back to

The Frontiers of Biotechnology Lecture Series

"Drugs from Bugs: Production of an Antimalarial Drug in Microbes"

View Webcast:  Broadband (220K)  |  Midband (80K)   [Download RealPlayer Free]

Presented by
Dr. Jay Keasling
Professor of Chemical Engineering and Bioengineering
Director, Berkeley Center for Synthetic Biology
University of California - Berkeley

Friday, December 2, 2005
3:15 pm
Building 66-110
Edwin R. Gilliland Auditorium

Dr. Jay Keasling

Jay Keasling Biography:
Dr. Jay Keasling received his B.S. in Chemistry and Biology from the University of Nebraska in 1986; his Ph.D. in Chemical Engineering from the University of Michigan in 1991; and did his postdoctoral work in Biochemistry at Stanford University from 1991-1992. Dr. Keasling joined the Department of Chemical Engineering at the University of California, Berkeley as an assistant professor in 1992, where he is currently professor.

Dr. Keasling is also a professor in the Department of Bioengineering at Berkeley, a faculty scientist and Director of the Physical Biosciences Division at the Lawrence Berkeley National Laboratory, and Director of the Berkeley Center for Synthetic Biology. Dr. Keasling has received several awards, including the CAREER Award from the National Science Foundation and the AIChE Award for Chemical Engineering Excellence in Academic Teaching, and has given several award lectureships, including the Inaugural Schwartz Lectureship at Johns Hopkins University and the Allan P. Colburn Memorial Lectureship at University of Delaware. Dr. Keasling's laboratory has engineered microorganisms to produce polymers and the anti-malaria drug artemisinin, as well as to accumulate uranium and to degrade nerve agents. Dr. Keasling is also a founder of two companies, Amyris Biotechnologies and Codon Devices, that have grown out of discoveries from his laboratory.

> Previous Biotechnology Lectures